EULAV ASSET MANAGEMENT – Global Blood Therapeutics, Inc. Transaction History
EULAV ASSET MANAGEMENT portfolio value:
$0
portfolio value
EULAV ASSET MANAGEMENT quarter portfolio value change:
+113.15%
quarter
Global Blood Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -380K shares | -12.14M | $68.1 | 0 |
| Q2 2022 | share | Decrease | -10.59% | -45K shares | -2.58M | $31.95 | 380K |
| Q1 2022 | share | Decrease | -15.00% | -75K shares | 87K | $34.64 | 425K |
| Q4 2021 | share | Increase | +11.11% | 50K shares | 3.16M | $29.86 | 500K |
| Q3 2021 | share | Increase | +9.76% | 40K shares | -2.89M | $25.48 | 450K |
| Q2 2021 | share | Increase | +18.84% | 65K shares | 299K | $35.02 | 410K |
| Q1 2021 | share | Increase | +7.81% | 25K shares | 200K | $40.75 | 345K |
| Q4 2020 | share | Increase | 0.00% | 320K shares | 13.85M | $43.31 | 320K |